Document Detail


Natural killer cell stimulatory factor (NKSF) augments natural killer cell and antibody-dependent tumoricidal response against colon carcinoma cell lines.
MedLine Citation:
PMID:  1673486     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The therapy of colorectal cancer may be improved by biologic response modifiers that enhance natural killer (NK) cell and antibody-dependent tumoricidal mechanisms. This study examined the effect of a recently discovered cytokine purified from the supernatant of an Ebstein-Barr virus-transformed B-lymphoblastoid cell line (RPMI-8866), natural killer cell stimulatory factor (NKSF), on NK and antibody-dependent cellular cytotoxicity (ADCC) of human colon adenocarcinoma cell lines. Human peripheral blood lymphocytes were cultured for 24 hr in the presence or absence of NKSF (3.6 pM) or interleukin-2 (1 nM). The cultured lymphocytes were analyzed for lytic potential toward chromium-51-labeled colon carcinoma targets SW 1116, 498 LI, and WC 1. ADCC was measured by incubating chromium-51-labeled SW 1116 or WC 1 targets with the monoclonal antibody CO17-1A, an IgG2a antibody reactive with gastrointestinal cancer-associated cell antigen, or control mouse IgG prior to testing NKSF-treated or control PBL effectors in a 6-hr cytotoxicity assay. NKSF significantly enhanced NK cytolysis of colon carcinoma and NK-resistant lymphoma cell lines, and on a molar basis was approximately 300 times more potent than interleukin-2 in generating NK cytotoxicity. Furthermore, NKSF significantly augmented lymphocyte-mediated ADCC against colon carcinoma targets, and the combination of NKSF with the antibody CO17-1A had an additive effect on lymphocyte tumoricidial capacity. Thus, NKSF may have a potential role in the treatment of colon cancer.
Authors:
M D Lieberman; R K Sigal; N N Williams; J M Daly
Related Documents :
3172636 - Anti-fx1a produces complement-dependent cytotoxicity of glomerular epithelial cells.
3235116 - Analysis of b. malayi microfilarial antigens by immunoblotting.
617926 - Antibody dependent and spontaneous lymphocyte mediated cytotoxicity in normal subjects,...
6973606 - T lymphocytes specific for immunoglobulin allotype. ii. cloned igh-1b-specific cytotoxi...
19212716 - Application of protein arraytubes to bacteria, toxin, and biological warfare agent dete...
6649986 - Immunodiagnosis of schistosomiasis haematobium and schistosomiasis mansoni in man. appl...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of surgical research     Volume:  50     ISSN:  0022-4804     ISO Abbreviation:  J. Surg. Res.     Publication Date:  1991 Apr 
Date Detail:
Created Date:  1991-05-28     Completed Date:  1991-05-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0376340     Medline TA:  J Surg Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  410-5     Citation Subset:  IM    
Affiliation:
Department of Surgical Research, University of Pennsylvania, School of Medicine, Philadelphia 19104.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antibody-Dependent Cell Cytotoxicity / drug effects*
Carcinoma / immunology*,  pathology
Colonic Neoplasms / immunology*,  pathology
HLA Antigens / analysis
Humans
Immunity, Cellular / drug effects
Interleukin-12
Interleukins / pharmacology*
Killer Cells, Natural / immunology*
Mice
Mice, Nude
Neoplasm Transplantation
Receptors, Fc / metabolism
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/HLA Antigens; 0/Interleukins; 0/Receptors, Fc; 187348-17-0/Interleukin-12

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Somatostatin-14 blocks the hepatotrophic effects of insulin in the rat.
Next Document:  Hairy cell transformation of a B-cell chronic lymphocytic leukemia: a morphological, cytochemical, p...